Trials / Sponsors / BioNova Pharmaceuticals (Shanghai) LTD.
BioNova Pharmaceuticals (Shanghai) LTD.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | The Effect of Food on the Pharmacokinetics of BN104 Tablets Health Subjects | Phase 1 | 2025-01-12 |
| Terminated | Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | 2022-11-25 |
| Withdrawn | A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL CLL/SLL, NHL | Phase 1 / Phase 2 | 2022-07-01 |
| Completed | Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD) GVHD, Chronic | Phase 2 | 2021-04-27 |